Short answer

When designing or managing pharmaceutical supply chains, actively address and potentially rebalance power dynamics to foster both proactive and reactive resilience.

Field
Innovation & Markets
Source
Supply Chain Management An International Journal (2023)
Method
Mixed-methods research
Sample
129 participants (23 qualitative, 106 quantitative)
Evidence
Strong effect

The exercise of power-based behaviours, such as quota systems and information control, has a complex and often contradictory impact on a pharmaceutical supply chain's ability to respond to disruptions. This innovation & markets research insight is drawn from a 2023 study published in Supply Chain Management An International Journal. Using Mixed-methods research with 129 participants (23 qualitative, 106 quantitative), researchers explored how this design variable affects real-world outcomes. The key design takeaway: When designing or managing pharmaceutical supply chains, actively address and potentially rebalance power dynamics to foster both proactive and reactive resilience.

Study
Innovation & MarketsRecentStrong effect

Power dynamics significantly shape pharmaceutical supply chain resilience strategies

The exercise of power-based behaviours, such as quota systems and information control, has a complex and often contradictory impact on a pharmaceutical supply chain's ability to respond to disruptions.

Supply Chain Management An International Journal · 2023

01

Key Findings

  • 01Power-based behaviours (quota systems, information and price control) influence proactive and reactive resilience strategies.
  • 02Power-based behaviours have a negative influence on reactive strategies and a positive influence on proactive strategies.
  • 03Supply chain complexities (stringent regulations, long lead times, complex production) moderate the negative impact of power-based behaviours on reactive strategies.
02

Application

Design takeaway

When designing or managing pharmaceutical supply chains, actively address and potentially rebalance power dynamics to foster both proactive and reactive resilience.

How to apply

When assessing supply chain vulnerabilities, explicitly map out power relationships and their potential impact on different types of resilience strategies.

Project actions

  • 01Consider how different stakeholders in your design project might have varying levels of influence.
  • 02Explore how these power differences could impact the success or failure of your design.
03

Method & Evidence

AimTo investigate the influence of power-based behaviours on the resilience strategies within pharmaceutical supply chains.
MethodMixed-methods research
ProcedureThe study involved qualitative interviews with 23 pharmaceutical supply chain stakeholders to understand perceptions of resilience, followed by thematic analysis. Quantitative propositions were then developed and tested through a survey administered to 106 stakeholders, with data analyzed using structural equation modelling.
Sample129 participants (23 qualitative, 106 quantitative)
ContextPharmaceutical supply chains

Variables

IVPower-based behaviours (e.g., quota systems, information control, price control)
DVPharmaceutical supply chain resilience strategies (proactive and reactive)
CVSupply chain complexities (stringent regulations, long lead times, complex production)
04

Strengths & Limitations

Strengths

  • +Utilizes a mixed-methods approach for a comprehensive understanding.
  • +Applies a Complex Adaptive System (CAS) perspective to analyze interactions.

Limitations

It can be challenging to objectively measure 'power' and its direct impact on resilience in a design project.

Reliability & validity

The use of structural equation modelling and thematic analysis suggests a robust approach to data analysis. However, the subjective nature of 'power' and 'resilience' could introduce potential validity concerns.

Think critically

To what extent can a supply chain be truly resilient if its core operations are dictated by power imbalances rather than optimal efficiency or risk mitigation?

05

Design Principles

"Supply chain resilience is influenced by the distribution and exercise of power among its actors."

Understanding how power imbalances influence supply chain operations is crucial for designing robust and adaptable systems. This insight highlights that while certain power dynamics might inadvertently foster proactive resilience, they can simultaneously undermine reactive capabilities, especially in complex regulatory environments.

06

What This Means for Your Design

How companies and people with more power in the drug supply chain affect its ability to handle problems.

How to use in your project

  • 1.Use this research to justify investigating power dynamics within your chosen design context.
  • 2.Cite this study when discussing how stakeholder relationships and influence affect design outcomes.
07

Add to My Project

08

Quick Cite

Paragraph starter

This research highlights that power-based behaviours within supply chains, such as information control and quota systems, significantly influence a supply chain's resilience. Specifically, these behaviours can negatively impact reactive strategies (immediate responses to disruptions) while positively affecting proactive strategies (long-term preparedness). The study also found that industry complexities, like stringent regulations, can exacerbate the negative effects of power imbalances on reactive capabilities. Therefore, when designing or evaluating supply chain systems, it is critical to consider the role of power dynamics among stakeholders and their potential to hinder or enhance overall resilience.

09

Source

Supply Chain Management An International Journal

The role of power-based behaviours on pharmaceutical supply chain resilience

journal · 2023

View source

Questions About This Research

What does the research say about power dynamics significantly shape pharmaceutical supply chain resilience strategies?
When designing or managing pharmaceutical supply chains, actively address and potentially rebalance power dynamics to foster both proactive and reactive resilience. Evidence: Supply Chain Management An International Journal (2023).
Why does "Power dynamics significantly shape pharmaceutical supply chain resilience strategies" matter for design?
Understanding how power imbalances influence supply chain operations is crucial for designing robust and adaptable systems. This insight highlights that while certain power dynamics might inadvertently foster proactive resilience, they can simultaneously undermine reactive capabilities, especially in complex regulatory environments.
How can designers apply this research?
When designing or managing pharmaceutical supply chains, actively address and potentially rebalance power dynamics to foster both proactive and reactive resilience.
What were the main findings?
Power-based behaviours (quota systems, information and price control) influence proactive and reactive resilience strategies.. Power-based behaviours have a negative influence on reactive strategies and a positive influence on proactive strategies.. Supply chain complexities (stringent regulations, long lead times, complex production) moderate the negative impact of power-based behaviours on reactive strategies.
What research method was used?
Mixed-methods research with 129 participants (23 qualitative, 106 quantitative).
How strong is the evidence?
Evidence strength is rated Strong effect, based on a 2023 journal from Supply Chain Management An International Journal.
What should I do differently in my next project?
When assessing supply chain vulnerabilities, explicitly map out power relationships and their potential impact on different types of resilience strategies.
What are the limitations?
The study's findings are specific to the pharmaceutical sector and may not directly translate to other industries. The 'complex adaptive system' perspective offers a framework but may not capture all nuances of human interaction.